Keeping a balance between DNA methylation and demethylation balance is central for
mammalian development and cell function, particularly in the hematopoietic system. In …

Peripheral T-cell lymphoma (PTCL) is a rare and heterogeneous group of clinically
aggressive diseases associated with poor prognosis. Except for ALK+ anaplastic large-cell …

Clonal hematopoiesis (CH) results from somatic genomic alterations that drive clonal
expansion of blood cells. Somatic gene mutations associated with hematologic …

Peripheral T-cell lymphomas (PTCLs) represent a group of rare hematological cancers of
mature T-cell or natural killer cell origin accounting for 10% to 15% of all lymphomas. 1 …

Historical advances in the care of patients with non‐Hodgkin lymphoma (NHL) have been
restricted largely to patients with B‐cell lymphoma. The peripheral T‐cell lymphomas …

Anaplastic large cell lymphomas (ALCLs) represent a relatively common group of T-cell non-
Hodgkin lymphomas (T-NHLs) that are unified by similar pathologic features but …

Abstract Pediatric‐type follicular (PTFL), marginal zone (MZL), and peripheral T‐cell
lymphoma (PTCL) account each for< 2% of childhood non‐Hodgkin lymphoma. We present …

Purpose Peripheral T-cell lymphomas (PTCLs) have aggressive clinical behavior. We have
previously shown that event-free survival (EFS) at 24 months (EFS24) is a clinically useful …

Recent advancements in comprehending peripheral T-cell lymphomas (PTCLs) validate and
broaden our perspective, highlighting their diverse nature and the varying molecular …

Peripheral T-cell lymphomas (PTCLs) are biologically and clinically heterogeneous
diseases almost all of which are associated with poor outcomes. Recent advances in gene …